A Neurologist Makes the Case for Integrative Medicine A Neurologist Makes the Case for Integrative Medicine
Dr Indu Subramanian talks with Dr Kathrin LaFaver about her research on loneliness in Parkinson's disease and why there's no such thing as one-size-fits-all wellness.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 27, 2021 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

BlueRock Therapeutics Announces New Board Chair, New President and CEO
CAMBRIDGE, Mass., July 26, 2021 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced today that Emile Nuwaysir, Ph.D., current President and CEO, ... Biopharmaceuticals, Neurology, Personnel BlueRock Therapeutics, Bayer AG, Parkinson's disease, engineered cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2021 Category: Pharmaceuticals Source Type: news

Covid vaccines confirmed to cause Parkinson's, dementia symptoms
(Natural News) Former National Institutes of Health (NIH) contract scientist and Classen Immunotherapies proprietor J. Bart Classen has published a paper warning that there is strong potential for Wuhan coronavirus (Covid-19) mRNA “vaccines” to trigger Parkinson’s, dementia and a variety of other prion and chronic diseases. Alzheimer’s, amyotrophic lateral sclerosis (ALS), and multiple system atrophy... (Source: NaturalNews.com)
Source: NaturalNews.com - July 26, 2021 Category: Consumer Health News Source Type: news

Drug Shows Promise in Easing Dementia-Linked Psychosis
FRIDAY, July 23, 2021 -- A drug that eases hallucinations in people with Parkinson's disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 23, 2021 Category: General Medicine Source Type: news

In conversation with Andy Cash, winner of the Hysteria 2020 poetry competition
Andy Cash was the winner of the Hysteria 2020 poetry competition with his poem The Poets Meeting published in the Hysteria 7 anthology. Andy writes about love, hope, human insecurities, death, our needs, mental illness and weaknesses, strengths, deep desires to be part of a fellow brethren and the lusts of life in an everyday world. He is anti-post truth and a fighter for freedom of the mind. Each poem he writes is about the truth, real people and real events. Listen to the interview and his reading of The Poets meeting https://lindaph.me/wp-content/uploads/2021/03/Andy-Cash.mp3 Key takeaways from this episode: Andy...
Source: The Hysterectomy Association - July 23, 2021 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Podcast author interview hysteria 2020 hysteria 2021 hysteria 7 poetry Source Type: news

The space between thoughts
The role of ‘thought’ in our experience of life and the world around us has been a defining understanding over the last few years for me. But it’s never been in such sharp relief as in the last 17 months. I am bemused by the observation of myself seesawing between different worries, concerns and misunderstandings as I try (along with the rest of humanity) to make sense of how we’ve got to where we are. What I seem to have forgotten along the way is how important the space between thoughts is when I get caught up in the moment to moment distractions called ‘information’. I have found myse...
Source: The Hysterectomy Association - July 22, 2021 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Spirituality thought Source Type: news

Parkinson's disease: How lysosomes become a hub for the propagation of the pathology
(Institut Pasteur) Over the last few decades, neurodegenerative diseases became one of the top 10 global causes of death. Researchers worldwide are making a strong effort to understand neurodegenerative diseases pathogenesis, which is essential to develop efficient treatments against these incurable diseases. A team of researchers found out the implication of lysosomes in the spread of Parkinson's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Evidence of sustained benefits of pimavanserin for dementia-related psychosis
(University of Exeter) A new paper published in the New England Journal of Medicine outlines a clinical trial, conducted in 392 people with psychosis associated with Alzheimer's disease, Parkinson's disease, Lewy body, frontotemporal, or vascular dementia. All participants were given pimavanserin for 12 weeks. Those who met a threshold of symptom improvement were then assigned to pimavanserin or placebo for up to 26 weeks. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Digital health technologies hold key to new Parkinson's treatments
(Critical Path Institute (C-Path)) The use of digital health technologies across health care and drug development has accelerated. A new paper titled " Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective, " co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2021 Category: International Medicine & Public Health Source Type: news

BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
CAMBRIDGE, Mass., July 19, 2021 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has grant... Regenerative Medicine, Neurology, FDA BlueRock Therapeutics, Bayer, Parkinson's disease, engineered cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2021 Category: Pharmaceuticals Source Type: news

Chemists found an effective remedy for " aged " brain diseases
(Ural Federal University) Scientists synthesized chemical compounds that can stop the degeneration of neurons in Alzheimer's, Parkinson's, and other severe brain pathologies. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 19, 2021 Category: International Medicine & Public Health Source Type: news

Predictive value of verbatim Parkinson's disease patient-reported symptoms of postural instability and falling - Javidnia M, Arbatti L, Hosamath A, Eberly SW, Oakes D, Shoulson I.
BACKGROUND: Postural instability is an intractable sign of Parkinson's disease, associated with poor disease prognosis, fall risk, and decreased quality of life. OBJECTIVE: 1) Characterize verbatim reports of postural instability and associated sym... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

The causes and impact of crisis for people with Parkinson's disease: a patient and carer perspective - Fearn S, Bartolomeu Pires S, Agarwal V, Roberts HC, Spreadbury J, Kipps C.
BACKGROUND: The reasons for acute hospital admissions among people with Parkinson's disease are well documented. However, understanding of crises that are managed in the community is comparatively lacking. Most existing literature on the causes of crisis f... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Effects of head trauma and sport participation in young-onset Parkinson's disease - Schirinzi T, Grillo P, Di Lazzaro G, Zenuni H, Salimei C, Dams-O'connor K, Sancesario GM, Mercuri NB, Pisani A.
Head trauma (HT) is emerging as an event anticipating onset of neurodegenerative disorders. However, the potential contribution of HT in young-onset cases (YOPD, age at onset  ... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
SAN DIEGO, July 13, 2021 -- (Healthcare Sales & Marketing Network) -- Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Ana Sousa ... Regenerative Medicine, Neurology, Personnel Aspen Neuroscience, Parkinson, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2021 Category: Pharmaceuticals Source Type: news

Dance Training'Drastically' Reduces Parkinson's Progression Dance Training'Drastically' Reduces Parkinson's Progression
Participation in weekly dance training classes"drastically" reduced the expected decline in motor function and improved quality of life in a study of patients with mild to moderate Parkinson's disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 13, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Compound derived from turmeric essential oil has neuroprotective properties
(Kumamoto University) Researchers from Kumamoto University, Japan have found that a component derived from turmeric essential oil, ar-turmerone, and its derivatives act directly on dopaminergic neurons to exert a neuroprotective effect on tissue cultures of a Parkinson's disease model. The effect appears to be due to the enhancement of cellular antioxidant potency through Nrf2 activation. The researchers believe that the ar-turmerone derivatives identified in this study can be utilized as new therapeutic agents for Parkinson's disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 13, 2021 Category: Biology Source Type: news

Anti-tumor agent from the intestine
It is believed to be involved in the development of chronic inflammatory intestinal diseases, to trigger diabetes, to be responsible for obesity, even neurological diseases such as multiple sclerosis and Parkinson's could have their causes here - not to mention depressions and autistic disorders. We are talking about the microbiome - the vast collection of bacteria in the human gut. It is estimated that each person carries around 100 trillion bacterial cells in their digestive tract, belonging to several thousand species. (Source: World Pharma News)
Source: World Pharma News - July 9, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Tetanus toxin fragment may treat depression, Parkinson's disease and ALS
(Universitat Autonoma de Barcelona) Researchers at the Universitat Autonoma de Barcelona describe the mechanism through which a non-toxic derivative of the tetanus neurotoxin (Hc-TeTx) may serve to treat depression and neurodegenerative diseases, as has already been demonstrated in animal models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2021 Category: International Medicine & Public Health Source Type: news

UCPH researchers prove powerhouse malfunction as the major cause of Parkinson's Disease
(University of Copenhagen - The Faculty of Health and Medical Sciences) The major cause of Parkinson's Disease is a dysregulation of immune genes central for fighting against viruses, a new study reveals. Researchers from the University of Copenhagen show that this dysregulation leads to a malfunction in the cell's powerhouse, which cannot produce sufficient energy for neurons to stay alive, causing them to gradually die. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2021 Category: International Medicine & Public Health Source Type: news

Exercising your happiness muscle
I believe happiness is always ours. What I mean by that is that it’s always there, lurking in the background, but sometimes for some of us, it’s been so covered up with sadness and the circumstances of life we’ve forgotten it exists for us, always. As I was wandering around my local village on my morning dog walk with The Beeble and Pip today it occurred to me happiness is a bit like a muscle that needs exercising; you know like the ones around our middle we can’t see but know if they were stronger or firmer our waist might be a little trimmer. Last week I was up around Chester and when I got back I...
Source: The Hysterectomy Association - July 8, 2021 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Happiness stillness Source Type: news

Mood disorders and anxiety in Parkinson's disease: current concepts - Lintel H, Corpuz T, Paracha SUR, Grossberg GT.
Mood disorders and anxiety significantly impact the prognosis and disease course of Parkinson's disease. Non-motor symptoms of Parkinson's disease such as apathy, anhedonia, and fatigue overlap with diagnostic criteria for anxiety and depression, thus maki... (Source: SafetyLit)
Source: SafetyLit - July 8, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Psychosis in Parkinson's disease: current treatment options and impact on patients and caregivers - Segal GS, Xie SJ, Paracha SUR, Grossberg GT.
Parkinson's disease (PD) is the second most common neurodegenerative disease seen in older adults after Alzheimer's disease, with increasing prevalence worldwide. Parkinson's disease psychosis (PDP) is a common, non-motor feature of PD, which increases car... (Source: SafetyLit)
Source: SafetyLit - July 8, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Dancing with music can halt most debilitating symptoms of Parkinson's disease
(York University) A new study shows patients with mild-to-moderate Parkinson's disease (PD) can slow the progress of the disease by participating in dance training with music for one-and-a-quarter hours per week. Over the course of three years, this activity was found to reduce daily motor issues such as those related to balance and speech, which often lead to social isolation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 7, 2021 Category: International Medicine & Public Health Source Type: news

Gerontotechnology for fall prevention: nursing care for older adults with Parkinson - Ferreira JM, Hammerschmidt KSA, Heideman ITSB, Alvarez AM, Santos SMAD, Fabrizzio GC.
OBJECTIVE: To assess the contribution of gerontotechnologies in nursing care to older adults with Parkinson's disease, aiming at the prevention of falls. METHOD: Convergent Assistance Research, through the development and evaluation of gerontechnol... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Impact of depression and anxiety on dimensions of health-related quality of life in subjects with Parkinson's disease enrolled in an association of patients - Chuquil ín-Arista F, Álvarez-Avellón T, Menéndez-González M.
The objective of this study is to determi... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

The burden of dementia due to Down syndrome, Parkinson's disease, stroke, and traumatic brain injury: a systematic analysis for the Global Burden of Disease Study 2019 -
BACKGROUND: In light of the increasing trend in the global number of individuals affected by dementia and the lack of any available disease-modifying therapies, it is necessary to fully understand and quantify the global burden of dementia. This work aimed... (Source: SafetyLit)
Source: SafetyLit - July 3, 2021 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news

GlaxoSmithKline, Alector enter into collaboration valued at up to $2.2B
The collaboration focuses on two new drug candidates under development for multiple neurodegenerative diseases including ALS and Alzheimer's and Parkinson's diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 2, 2021 Category: Pharmaceuticals Authors: John George Source Type: news

"Going Backward": Effects of age and fatigue on posterior-directed falls in Parkinson disease - Papa EV, Patterson RM, Bugnariu N.
BACKGROUND: Nearly half of persons with Parkinson disease (PD) report fatigue as a factor in their fall history. However, it is unknown whether these self-reported falls are caused by a sensation of fatigue or performance fatigue. OBJECTIVE: We sou... (Source: SafetyLit)
Source: SafetyLit - July 2, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Discovery of nanosized molecules that might inhibit Alzheimer's and Parkinson's diseases
(Umea University) Nanosized molecules of a particular chemical element can inhibit the formation of plaque in the brain tissues. This new discovery by researchers at Ume å University, Sweden, in collaboration with researchers in Croatia and Lithuania, provides renewed hope for novel treatments of, for instance, Alzheimer's and Parkinson's disease in the long run. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2021 Category: International Medicine & Public Health Source Type: news

IU researchers pioneering noninvasive technique for neurological conditions
(Indiana University School of Medicine) Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson's disease, Alzheimer's disease and more. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2021 Category: International Medicine & Public Health Source Type: news

Stem Cell Transplant Treats Parkinson & rsquo;s Disease in Monkeys
(Source: The Scientist)
Source: The Scientist - July 1, 2021 Category: Science Tags: Sponsored Article Source Type: news

Stem Cell Transplant Treats Parkinson ’s Disease in Monkeys
Personalized stem cells improved motor symptoms and depression signs in monkeys modeling Parkinson ’s disease, paving the way for trials in human patients. (Source: The Scientist)
Source: The Scientist - July 1, 2021 Category: Science Tags: Sponsored Article Source Type: news

Human stem cells enable model to test drug impact on brain's blood barrier
(KTH, Royal Institute of Technology) Using an experimental model to simulate the blood-brain barrier, scientists in Sweden reported in unprecedented detail how antioxidants protect the brain from inflammation caused by such neurodegenerative diseases as Alzheimer's and Parkinsons. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2021 Category: International Medicine & Public Health Source Type: news

In memoriam: Dr. Gerald S. Levey, 84, oversaw building of Ronald Reagan UCLA Medical Center
Dr. Gerald Levey, who led the transformation of UCLA ’s hospitals and medical school into a world-class academic health system, died at home of Parkinson’s disease on June 25. He was 84. Levey served the campus as vice chancellor of medical sciences and dean of the David Geffen School of Medicine at UCLA from 1994 to 2010. During his tenure, Levey amassed an extraordinarily long list of achievements, crowned by the construction of the Ronald Reagan UCLA Medical Center and the sealing of a $200 million gift to the UCLA School of Medicine by entertainment executive David Geffen.  “It&rsq...
Source: UCLA Newsroom: Health Sciences - June 30, 2021 Category: Universities & Medical Training Source Type: news

Human molecule blocking toxic forms of Parkinson's-related protein identified
(Universitat Autonoma de Barcelona) Researchers at the UAB and the UniZar have identified a human peptide found in the brain that blocks theα-synuclein aggregates involved in Parkinson's disease and prevents their neurotoxicity. The study, published in Nature Communications, suggests that this could be one of the organism's natural mechanisms with which to fight aggregation. The discovery may help to develop new therapeutic and diagnosis strategies for Parkinson's disease and other synuclein pathologies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 29, 2021 Category: Biology Source Type: news

Clinical relevance of fear of falling in patients with Parkinson's disease - Kwon KY.
[The publisher has not provided an abstract for this article.] Language: en... (Source: SafetyLit)
Source: SafetyLit - June 28, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Fear of falling: an independent factor affecting health-related quality of life in patients with Parkinson's disease - Albay VB, Tutuncu M.
BACKGROUND: Fear of falling (FOF) is a serious problem in Idiopathic Parkinson's Disease (IPD) which increases mortality and affects Health Related Quality of Life (HRQoL). OBJECTIVE: To evaluate the effect of FOF on HRQoL in IPD. METHODS: ... (Source: SafetyLit)
Source: SafetyLit - June 28, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Video analysis of safety and reproducibility issues with the timed up-and-go test applied to patients with Parkinson's disease - Fujii C, Wakizaka N, Araki Y, Tashiro K, Endou M.
PURPOSE: Falls are a major problem and cause poor quality of life and reduced life expectancy in people affected by Parkinson's disease (PD). The timed up-and-go (TUG) test is the most popular test of walking ability in patients with PD. However, it carrie... (Source: SafetyLit)
Source: SafetyLit - June 28, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Excessive Drooling a Sign of Greater Dysfunction in Parkinson's Excessive Drooling a Sign of Greater Dysfunction in Parkinson's
Patients with Parkinson's disease who experience excessive drooling are at greater risk for motor and nonmotor dysfunction as well as respiratory tract infections, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 24, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Caryn Peterson Joins Aspen Neuroscience Board of Directors
SAN DIEGO, June 23, 2021 -- (Healthcare Sales & Marketing Network) -- Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Caryn Pete... Devices, Regenerative Medicine, Neurology, Personnel Aspen Neuroscience, Parkinson, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2021 Category: Pharmaceuticals Source Type: news

AI model predicts Alzheimer's disease brain changes on MRI
An artificial intelligence (AI) model trained on MRI scans identified variation...Read more on AuntMinnie.comRelated Reading: AI classifies severity of Parkinson's on 3D SPECT AI enables noninvasive tumor pathology mapping on brain MRI MIDRC offers support for COVID-19 AI AI proves effective for triaging abnormal brain MRI results AI-based reconstruction speeds up quantitative volumetric MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 23, 2021 Category: Radiology Source Type: news

Parkinson’s disease: Facial masking an early warning sign - four body parts affected
PARKINSON'S disease is a condition that affects the brain. It causes problems like shaking and stiffness that get worse over time. The condition is also known to affect a person's emotional response due to the loss of motor control, and four body parts can be affected. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2021 Category: Consumer Health News Source Type: news

Autopsy Study Shows How COVID Harms the Brain
TUESDAY, June 22, 2021 -- The brains of people who died from COVID-19 were remarkably similar to the brains of people who die from neurodegenerative diseases such as Alzheimer's and Parkinson's, showing inflammation and disrupted circuitry,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 22, 2021 Category: General Medicine Source Type: news

Neurodegeneration Complicates Psychiatric Care in Parkinson's Neurodegeneration Complicates Psychiatric Care in Parkinson's
While the exact mechanism for depression and anxiety's link to Parkinson's disease is unknown, both occur with increased prevalence across the disease course, experts say.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 21, 2021 Category: Primary Care Tags: Psychiatry News Source Type: news

In conversation with Jane O ’ Connor, winner of the Hysteria 2020 short story competition
Jane O’Connor was the winner of the Hysteria 2020 short story competition with her story The Flower Box published in the Hysteria 7 anthology. Jane is a writer of short stories and novels, as well as a researcher and reader in Childhood Studies at Birmingham City University. Her latest novel,’The Trial of Gwen Foley‘ is due out July 2021 and published by @Bloodhoundbook Listen to the interview and her reading of The Flower Box https://lindaph.me/wp-content/uploads/2021/03/Jane-oconnor.mp3 Key takeaways from this episode: Jane began writing fiction during her second maternity leave. The novel she st...
Source: The Hysterectomy Association - June 18, 2021 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Podcast author interview hysteria 2020 hysteria 2021 hysteria 7 Source Type: news

Will reduction in tau protein protect against Parkinson's and Lewy body dementias?
(University of Alabama at Birmingham) Will a reduction in tau protein in brain neurons protect against Parkinson's disease and Lewy body dementias? A new study suggests the answer is no. If this is borne out, that result differs from Alzheimer's disease, where reducing endogenous tau levels in brain neurons is protective for multiple models of the disease -- and thus suggests that the role of tau in the pathogenesis of Lewy body dementias is distinct from Alzheimer's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2021 Category: International Medicine & Public Health Source Type: news

Controlling brain states with a ray of light
(Institute for Bioengineering of Catalonia (IBEC)) A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive to light, named PAI. The results not only pave the way to act on the brain patterns activity and to understand their connection to cognition and behavior, but they also could lead to the development of photomodulated drugs for the treatment of brain lesions or diseases such as depression, bipolar disorders or Parkinson's or Alzheimer's diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2021 Category: International Medicine & Public Health Source Type: news

Ex-England captain Mike Tindall reunites with dad with Parkinson's
The year Mike Tindall won the Rugby World Cup was the same year his father received his diagnosis. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 16, 2021 Category: Consumer Health News Source Type: news

Parkinson's disease: Mike Tindall's dad on how symptoms appeared 'I tried to ignore it'
MIKE TINDALL is an English former rugby player, married to royalty - Zara, the daughter of Princess Anne and Captain Mark Phillips. Together, they share three children: Mia, Lena, and Lucas. (Source: Daily Express - Health)
Source: Daily Express - Health - June 16, 2021 Category: Consumer Health News Source Type: news